Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Just looked at this site my trade must of been around 10.am there time .
Can not see a lot of information on trades .
I wonder what the spread is ? 0.079 to 0.08 approx 1.5%
Yesterdays exchange rates 9.4841 & 9.4826 today's 9.4365.
Note ticker is 0575
http://www.aastocks.com/en/stocks/quote/detail-quote.aspx?symbol=00575
Ripley
I'm just a little confused regarding your sale . Were you talking about selling the rights to the rights issue or selling actual shares you hold since, as I posted a day or two back, there were 130 mill rights (not shares) up for sale at 0.01 which makes sense given the sp was around 0.75. Anyone could buy the rights and although it would add 0.01 to the price that would be needed for the rights shares, they could effectively buy 130mill without impacting the SP. if one were to try and buy that many shares on the open market, they would probably need to pay double if not treble the current sp.
As I also wrote, if you managed to sell the rights (not the shares) at 0.79 etc, good for you, although I really think there must be a misunderstanding on my part as to what you were selling. I think The.Italian was/is a little confused too.
As to why I bought in. I did so because there is obviously potential for the product given what else is available, however. Shareholders have been deeply let down by incompetence in management who have no idea what they are doing. That and all the BS they have continued to regurgitate to shareholders regarding cream tomorrow. As I wrote recently, they were supposedly to have had discussions with the FDA in 2014 and agreed an unambiguous way forward, meaning they must have agreed a list of requirements to achieve FDA approval which they stated would be forthcoming mid 2017. Little did shareholders know that it was all made up fantasy and nothing more than lies.
That said I chose to continue to hold because there is definitely going to be fireworks once the Chinese approval comes through and of course finally the FDA which is still up in the air given it has taken them 4.5 years just to get this far with the phase II (and we still have not had approval to continue with phase III). There is much that new shareholders don't know about the companies antics and pie in the sky schedules, which can be found if one were to choose to wade back through all the announcements to 2015, unfortunately the PLE announcements (RNS's) and presentations are no longer available to download, although I do have most of them which do make some interesting reading with respect to unkept timelines.
Anyway, I'm sure 2023 will be a turning point in the companies and our fortunes........but then again, we are relying on incompetence to get us across the line wrt FDA, so at the end of the day. Its anybody's guess. Mind you we are fortunate that the Chinese approval process is not in ERP's hands but with the experienced professionals in China who have managed to get us close to approval in less than half the time its so far taken ERP to obtain FDA approval and even with double the number of test subjects.
Ripley
If you are interested in urology products of the sexual nature. You might want to look at FUM since they are waiting on FDA approval for a fast acting OTC ED gel which could take a chunk of the Viagra and Cialis markets, both of which take a while to to work and need a script. Approval is only a matter of weeks away and could rocket the sp onto a new and never before seen level.
No advice given, but take a squizz and DYOR.
bignose58 I did post I had bought real shares in recent weeks , it was those I sold .
I bought partly after reading the two of you posters here claiming I might not get any rights .
I sold partly as you two are not keen on rights price ?
I made a little bit . ( 0.074 to 0.08 is approx 8% )
At this point in time I will be buying my rights .
I always wait until deadline , but that might not be wise this time of year .
I suspect the company guessed this would affect take up , another reason I will buy .
I know hardly anything of urology products of the sexual nature , a broker at SVS ( specialists in raising funds for AIM before being shut down by FCA , suggested this share , informing me of large amount of men with this problem )
He might of mentioned JM .
Years ago when it was free I read share prophets ( not sure what there take was , I think there view changes as they buy and sell )
Was this product pre Viagra ?
Has that not captured the market ?
Ridley,
With respect to our product. It’s for PE (premature ejaculation) with the same number of sufferers as ED (Erectile Dysfunction). Given that and the fact that there are now numerous approved ED similar products on the market which still make huge profits for the owning companies, ERPs product should do reasonably well since there are only one or two approved products aaable.
I write reasonably well since there is a lot more stigma attached to the vinegar stroke than there is to obtaining wood, however. Given time, just like what occured with ED drugs, men will became more bold in admitting they have a problem and the number “coming out” will increase. Also, with the China approval, that means exposure to approx 187.5 million sufferers. In the US that number is approx 42 mill and in Europe (E5 - the 5 largest economies/most people) it’s approx 32mill. The EU now has OTC approval meaning a sufferer only has to visit a pharmacy and buy off the shelf rather than visit a doctor for a script (to be relaunched OTC in 2023 due to manufacturing problems which have apparently been solved). Even with the stigma attached and the uptake % being low, they are still large figures if an av can cost of 75usd is assumed. (The Chinese are targeting 9 mill sufferers alone in year 1 after approval ie probably commencing sometime next year). Also note that once a can holds 12 doses, most will probably be buying 2 to 3 cans a year (the products effects wear off if one stops applying it)
Of course those numbers are not reflected in the sp because the company keeps running out of Money and management have time and time again shown they are totally incompetent with no business acumen. As such, investors have left the building and the market has lost all confidence in the company, however. Once sales take off, investors should be flooding back particularly when they think money is to be made with respect to sp rise and dare I write dividends.
"You might want to look at FUM "
I have noticed the name cropping up over the years is it a much different product ?
This seems to be one which share prophets buy and sell do either of you own it ?
I personally don’t, but I have watched it for a long time. They have had ups n downs with different products which never took off, however. This lates ED gel looks like it could be a game changer.
FUMs product is for ED lots of competition, ours is for PE with not much competition.
bignose58
Thank you for that education on the difference between this product and Viagra I always thought PE was something "first trimmers" to sex might experience and the over overexcited .
I am and was at time of recommendation, surprised there was such a market .
PE is as common amongst men as ED, ie 25% of men suffer from it (although I have read a few times it’s closer to 30%). So you can see the potential here. It’s just unfortunate it’s being managed (approval timelines and licenses) by a bunch of clowns.
afternoon all excellent summary on ERP bignose. my own view,which i think reflects also,big nose's, is that for those of us who have been invested for many years (from 2013 in my case and longer for bignose) we are approaching the point where it will be determined if the company is ever going to have a successful product or not, fda approval is still some way off, but we can see it on the horizon.eu sales should now be possible with the new manufacturer.the original problem of being only available RX as opposed to OTC,meant that sales were minimal. if we can get OTC approval in the US,(which i personally think we will,although to what time scale i can't say)then the sales' potential is significantly increased.as bignose says,the main problem is the company has never made any profits and has no cash to speak of.this will be partially addressed by the rights issue,but much of that is going to pay down existing debt.the ceo is,with respect,paid a ludicrous salary,totally out of proportion to the m/c of the company and its performance record.there is little likelihood that that will change. i am slightly encouraged that mellon is still prepared to put money in,but tbh,it's small change to him.that said,no one likes to lose money so i'm interpreting it as a very small measure of confidence in the prospects,but nothing more.personally i shall remainninvested until FDA approval,unless something very untoward happens(im pretty elderly!),but would not commit further funds of any substance in view of the history and lack of confidence in the bod. one point to remember is that it seems generally accepted that fortacin actually works and it has a very good safety profile(this is the reason im expecting FDa approval at end of day.the big questions are can they sell it in any volume and will they have enough money to get to the point?
Amusing, but a bit sad, that the hoary old misconceptions regarding market drivers still persist in the face of real life events, as does the magical thinking that somehow prescriber/punter perception of a run of the mill knob spray is going to be somehow different in other territories.
And perhaps best not to get all unnecessary over FDA progress- those of you with of a statistical bent might care to take a gander at the data in the study report, specifically ITT population breakdown, placebo response rate and spread around the means. Hardly confidence-inspiring...
Just had a look here as I have not heard from my broker , since excepting the offer .
No money taken so was worried they had missed it .
But after reading here only 25% take up, wish I had not sent a reminder email .
As a mistake by them not auctioning might be in my favor lol
I think this link will be better. Note ticker is 0575
http://www.aastocks.com/en/stocks/quote/detail-quote.aspx?symbol=00575
Still no word from my broker the price is holding @ 0.079 .
My buy lifted in two parts 30 November and 15 December 2022 at 0.073.
About 6 trades a day .
My broker Degiro has told me brokerage department could not processes rights .
Advising I can buy at current price and request compensation if more expensive which they might or not agree to .
Falling back on there best effort clause .
Looks like you would have to pay 0.089 to buy yesterday that is more then 12.5% above the offer price of 0.079.
So if Jim is now then majority shareholder the SP isn’t going to move unless sales and good or we get licences in USA or China. Jim must be extremely hopefully of this as he has put millions in here.
Both well,
Given that there will be less free shares in circulation, surely sp movements could be more volatile. Yes there are double the number of shares, but effectively most are now out of circulation being held by the A team.
But I do agree that he must feel it’s worth holding on to, although his investment is still pocket change to him. (Especially since he must realise only a few LTH’s were willing to invest hence the huge underwriting of the shares which are on him).
evening all. lets hope we are right and mellons increased investment is indeed an expression of confidence.it is small change to him, but i expect even billionaires (or whatever he is) don't like to lose money and probably wouldn't have got to be one if they were indifferent to risk.so in a spirit of optimism, im going with the view that it indicates it least an opinion that the risks are well balanced by the possible rewards. interested to see that the s/p has hit a level just above the theoretical ex rights price of 0.093 hkd quoted when setting out the terms of the proposed issue. fingers crossed for some positive news soon.
Jim isn’t just going to sink money in hoping there is a positive outcome. He must know that there is a strong possibility of success and the opportunity to make much more than he put in. It has been a long time in the making but profits for us might not be too far away……
well one would certainly hope so. obviously he is going to be up to speed on developments with the FDA in a way which the rest of us are not, so strongly suggestive of positive news on that front .
I’m only guessing here, but I cannot help but feel phase iii may have already started. I only write this since there has been a total block on information and given that it’s Dr Mike who updates the gov website, I would suspect that he has been advised to not do so.
I could be totally wrong, but I can’t for the life of me see why there have been no updates regarding the Q&A process.
Just my opinion on the matter of course ;-)
afternoon bignose.odd ,but i was wondering the same thing myself earlier today when i was looking to see if there had been any update to the QC section on the fda site. it just seems a bit extreme for nothing to have happened since the 22nd oct.there are only 2 queries. as you say just a guess,but does seem to have been a complete embargo on news,e.g. manufacturer.
Is Dr Mike still involved or has he pulled out? Sure I read he had resigned?